You are hereMay 11, 2020
COVID-19 Treatment Developed by UAE Stem Cell Center
ABU DHABI (AE), May 2020 — A patent has been granted by the United Arab Emirates Ministry of Economy for the development of a promising treatment for COVID-19 infections using stem cells. The treatment was developed by a team of doctors and researchers at the Abu Dhabi Stem Cell Center, ADSCC, and involves extracting stem cells from the patient’s own blood and reintroducing them after activating them.
The patent was granted for the method in which the stem cells are collected.
The treatment was administered in the UAE to 73 COVID-19 patients who have all been successfully treated for the virus by inhaling the treatment into their lungs after it has been nebulized into a fine mist. It is hypothesized to have its therapeutic effect by regenerating lung cells and modulating the immune response to keep it from overreacting to the COVID-19 infection and causing further damage to healthy cells.
The treatment has undergone the initial phase of clinical trials, demonstrating its safety. None of the patients who received the treatment reported immediate adverse effects and there have been no interactions found with the conventional treatment protocols for COVID-19 patients.
Trials to demonstrate the efficacy of the treatment are ongoing and are expected to be completed in a couple of weeks.
The treatment has been given to patients along with the conventional medical intervention and will continue to be applied as an adjunct to established treatment protocols rather than as a replacement.